Publications

Letter Ahead of print

PubMed: 42706951 DOI: 10.1111/jdv.70719

Response to methodological concerns in cumulative isotretinoin dose trials.

J Eur Acad Dermatol Venereol

Authors: Ruggero Cascio Ingurgio, Angela Alfano, Antonio Costanzo, Julie S Cronk, Rebecca Cummins, Benjamin S Daniel, Ben J Koszegi, Linda K Martin, Clarisse G Mendoza, Mae Ramirez-Quizon, Lesley M Rhodes, Heather I Rishel, Adam I Rubin, Fanny Satgé, Supriya Venugopal, Anna Wilson, Dedee F Murrell

Affiliations

  • Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.
  • Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
  • Dermatology Consultants, Woodbury, Minnesota, USA. Minneapolis VA Medical Center, Minneapolis, Minnesota, USA.
  • Department of Dermatology, Children's Hospital, Northwestern University, Chicago, Illinois, USA.
  • Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
  • Department of Dermatology, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.
  • Department of Dermatology, St George Hospital, Sydney, New South Wales, Australia.
  • Melanoma Institute Australia, the University of Sydney, Sydney, New South Wales, Australia.
  • Immunodermatology Unit, Research Institute for Tropical Medicine, Muntinlupa, Philippines.
  • Department of Dermatology, Rizal Medical Center, Manila, Philippines. Department of Dermatology, Philippine General Hospital, Manila, Philippines.
  • Rishel Enterprises, LLC, San Francisco, California, USA.
  • The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York, USA.
  • Dermatologie et vénérologie, CHU de la Réunion, Saint-Pierre, France. Department of Rheumatology, Centre Hospitalier Universitaire de La Réunion, Hôpital Felix Guyon, Saint Denis, La Réunion, France.
  • Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia. Department of Dermatology, St George Hospital, Sydney, New South Wales, Australia.

MeSH

Isotretinoin, Sexually Transmitted Diseases, Skin Diseases, Contraceptives, Oral, Acne Vulgaris